# Bonit Capital

> Bonit Capital is a VC fund in Stockholm backing Health Care and Medical. See 13 investments, check sizes, portfolio and contact details. Updated Aug 2026.

- Type: VC Fund
- Location: Stockholm, Sweden
- Total investments: 13
- Last investment: Oct 2023
- Lead investor: 31%
- Last updated: Aug 2026
- LinkedIn: https://www.linkedin.com/company/bonit-capital/
- Website: http://bonitcapital.com

Bonit Capital is a Swedish family-owned investment company. We invest across sectors and asset classes, including social investments and outcome models.Venture Capital - We invest in ambitious founders within the life science sector. We take an active ownership approach by providing capital, industry expertise and access to an internationalnetwork. Our focus areas are digital health, medical technology and diagnostics.Private Equity - We invest in entrepreneurial teams with deep sector expertise and unique market access, primarily in the lower to mid-market buyout segment, with the aim to produce superior returns and meaningful portfolio diversification.Listed Equity - Our strategy is to obtain a broad market exposure through mainly external mandates, and to seek superior returns in individual shares primarily in life science. Among Bonit's main holdings are the world-leading medtech company Elekta AB, founded by Laurent Leksell.Leksell Social Ventures - LSV is the first impact investor in Sweden with a focus on outcome models and direct investments in the areas of mental health, education and social integration. Striving for systemic change, LSV contributes to social innovation and societal development by giving social entrepreneurs and social ideas the necessary prerequisites to develop and progress – through financing, idea development and networking with private, public and nonprofit actors.

## Contacts

5 contacts available for Bonit Capital. Shizune tracks 1 team members at Bonit Capital. Sign up free to unlock them: https://app.shizune.co/sign-up/investor-profiles/find-team-emails/bonit-capital?utm_source=investor_profile

## Round sizes

| Stage | Round size |
| --- | --- |
| Seed | $1.8M–$4.2M |

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Health Care | 7 | 54% |
| Medical | 5 | 38% |
| Apps | 2 | 15% |
| Internet | 2 | 15% |
| Software | 2 | 15% |

18 industries tracked in total.

### Stage

| Stage | Investments | Share |
| --- | --- | --- |
| Funding Round | 5 | 38% |
| Seed | 3 | 23% |
| Series A | 1 | 8% |
| Series B | 1 | 8% |
| Venture - Series Unknown | 1 | 8% |

### Country

| Country | Investments | Share |
| --- | --- | --- |
| Sweden | 5 | 38% |
| United States | 2 | 15% |
| Germany | 1 | 8% |
| United Kingdom | 1 | 8% |

## Team

| Name | Title | Investments | Profile |
| --- | --- | --- | --- |
| Richard Leksell | Partner | 12 | https://shizune.co/investors/profile/richard-leksell |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| Bentley | Bentley engages in the development, manufacturing for minimal-invasive treatments of vascular diseases. |  |  | Oct 27, 2023 |  |
| Alex Therapeutics | Alex Therapeutics, a digital therapeutics company, is changing the way clinicians provide support for patients to change unwanted habits leading to poor medical outcomes. Our proprietary AI-platform is used as the basis when we develop CE-marked software medical devices (Class I) apps for a variety of therapeutic areas. | $5.1M | Venture - Series Unknown | Mar 03, 2023 |  |
| Alex Therapeutics | Alex Therapeutics, a digital therapeutics company, is changing the way clinicians provide support for patients to change unwanted habits leading to poor medical outcomes. Our proprietary AI-platform is used as the basis when we develop CE-marked software medical devices (Class I) apps for a variety of therapeutic areas. | $3.8M |  | Apr 06, 2022 |  |
| Alex Therapeutics | Alex Therapeutics, a digital therapeutics company, is changing the way clinicians provide support for patients to change unwanted habits leading to poor medical outcomes. Our proprietary AI-platform is used as the basis when we develop CE-marked software medical devices (Class I) apps for a variety of therapeutic areas. | $3.8M | Venture - Series Unknown | Apr 06, 2022 |  |
| Vården.se | Vården.se is Sweden's largest private search service in healthcare and health . |  | Seed | Jul 17, 2020 |  |
| Vården.se | Vården.se is Sweden's largest private search service in healthcare and health . |  | Seed | Jul 17, 2020 |  |
| Medpeople | Medpeople is a cloud-based solution for healthcare staffing where licensed doctors and nurses via an app can take the task and start working as consultants. By automating the manual work currently done by traditional staffing companies disappear "intermediaries". Job History, pay, scheduling and communications are handled directly in theapp and provides a simple turnkey solution for both healthcare providers and consultants. | $965K |  | Jan 23, 2020 |  |
| Meru Health | Meru Health offers a digital program that helps improve the lives of people living with depression and saves on healthcare costs. It develops and delivers cost-effective, clinically proven, and engaging digital solutions to empower people living with depression.Founded by Kristian Ranta, Albert Nazander, and Riku Lindholm in 2015, Meru Health isheadquartered in San Mateo, California. | $4.2M | Seed | Apr 25, 2019 |  |
| ScientificMed | ScientificMed provides healthcare givers and patients access to state-of-the-art e-treatment solutions with the goal of improving treatment outcomes, empowering the patients, and increasing the efficiency of healthcare delivery.​They are a group of skilled and experienced professionals with a diversity of backgrounds that all unite to a greatteam working smart and focused together to achieve their goals. | $965K |  | Jan 18, 2019 |  |
| Invicta Medical | Invicta Medical operates as a medical technology company that develops therapies for sleep apnea. Its neurostimulation wearable is designed to address the shortcomings of existing therapies, which are expensive, intrusive, and yield low patient compliance rates. The company was founded in 2013 and is headquartered in Santa Clara, California. | $21M | Series B | Jan 02, 2018 |  |

10 of 13 investments shown.

## Co-investors
- [Hadean Ventures](https://shizune.co/investors/profile/hadean-ventures) — VC Fund, 3 deals together
- [R Ventures](https://shizune.co/investors/profile/r-ventures) — VC Fund, 3 deals together
- [Scale Capital](https://shizune.co/investors/profile/scale-capital) — VC Fund, 3 deals together
- [Sweet Studio](https://shizune.co/investors/profile/sweet-studio) — VC Fund, 2 deals together
- [Thiel Capital](https://shizune.co/investors/profile/thiel-capital) — VC Fund, 2 deals together
- [20 North Street](https://shizune.co/investors/profile/20-north-street) — VC Fund, 1 deal together

## Similar investors

### Similar industry
- [Antler](https://shizune.co/investors/profile/antler-be9c) — VC Fund
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [Right Side Capital Management](https://shizune.co/investors/profile/right-side-capital-management) — VC Fund

### Similar stage
- [Bpifrance](https://shizune.co/investors/profile/bpifrance) — VC Fund
- [SFC Capital](https://shizune.co/investors/profile/startup-funding-club) — VC Fund
- [HTGF (High-Tech Gruenderfonds)](https://shizune.co/investors/profile/high-tech-gr%C3%BCnderfonds) — VC Fund

### Similar country
- [Almi Invest](https://shizune.co/investors/profile/almi-invest) — VC Fund
- [Chalmers Ventures AB](https://shizune.co/investors/profile/chalmers-ventures) — VC Fund
- [Antler](https://shizune.co/investors/profile/antler-be9c) — VC Fund

## Featured in investor lists
- [Health Care VC Funds in Sweden](https://shizune.co/investors/health-care-vc-funds-sweden)
- [SaaS VC Funds in Sweden](https://shizune.co/investors/saas-vc-funds-sweden)
- [Medical VC Funds in Sweden](https://shizune.co/investors/medical-vc-funds-sweden)
- [Artificial intelligence VC Funds in Sweden](https://shizune.co/investors/artificial-intelligence-vc-funds-sweden)

## FAQ

### What does Bonit Capital invest in?

Bonit Capital invests primarily in Health Care, Medical and Apps startups, most often at Funding Round and Seed stage. Most of the 13 investments tracked by Shizune back companies in Sweden. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### What is Bonit Capital's check size?

Bonit Capital typically joins rounds of $1.8M–$4.2M at Seed. These ranges are 10th–90th percentile round sizes calculated from confirmed public funding rounds, so they are a realistic guide to the rounds Bonit Capital participates in.

### How do I contact Bonit Capital?

Public channels for Bonit Capital include LinkedIn and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.

### Who are the partners at Bonit Capital?

The team at Bonit Capital includes Richard Leksell (Partner). The Team section lists each member with their title, investment count and links.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co